Weil adds leaders from Latham to head up tech and life sciences

The trio bring experience in patent, trade secret, and commercial disputes across high tech, biotech, and life sciences, with two returning to Weil after more than a decade.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

Carpmaels & Ransford builds Munich UPC team with elite hire

12 January 2026 Experienced Ex-Hoffmann Eitle litigator who worked on Sanofi v Amgen joins firm’s growing UPC team in Germany.

Careers

‘All voices must be heard’: New CIPA president sets out plans for 2026

9 January 2026 Simon Wright says he will focus on engagement with in-house and SME members, as well as support the UK rejoining the UPC and more as he takes the reins at the Chartered Institute of Patent Attorneys.

Careers

Arnold & Porter loses another regulatory partner to growing rival

7 January 2026 A Brussels-based partner, specialising in pharmaceuticals and biologics, jumps ship as a competitor firm continues to build out its EU healthcare regulatory bench.

More features

Carpmaels & Ransford builds Munich UPC team with elite hire

Why the US is poised for a patent litigation surge in 2026

From migraine drugs to COVID vaccine spats, US lawsuits pile up

How AI will be shaped by legal and regulatory developments in 2026

Deadline extended: Who are the world’s best in-house counsel?

‘All voices must be heard’: New CIPA president sets out plans for 2026

Insulin pump rivals face off in major trade secrets dispute hearing

Bayer enters COVID-19 vaccine row with three suits against major drugmakers

Weil adds leaders from Latham to head up tech and life sciences

More on this story

Editor's picks

Editor's picks

More features